About Jonathan Bell
Jonathan Bell is a president and director at Amptiv Biosciences.
Jonathan Bell first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Jonathan Bell in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jonathan Bell works with at each company, as listed on that company's latest Form D.
Amptiv Biosciences, Inc. · Form D, Apr 4, 2025
JA
Jon Armstrong
Director